Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients: Complete Statistical AnalysisIndependent statistical analysis of Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Tecnis ZLB00 & Symfony Intraocular Lens Combination Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Tecnis ZLB00 & Symfony Intraocular Lens Combination Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03771274).
- TECTONICSIndependent statistical analysis of Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- TeenThriveIndependent statistical analysis of Treatments for Improving Mood in Depressed Teens-3: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03831360).
- Telavancin Pediatric PK Study (Ages >12 Months to 17 Years): Complete Statistical AnalysisIndependent statistical analysis of Telavancin Pediatric PK Study (Ages >12 Months to 17 Years): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02013141).
- Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies: Complete Statistical AnalysisIndependent statistical analysis of Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00142298).
- Telehealth Delivery of Treatment for Sleep Disturbances in Young Children With Autism Spectrum Disorder: Complete Statistical AnalysisIndependent statistical analysis of Telehealth Delivery of Treatment for Sleep Disturbances in Young Children With Autism Spectrum Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TeleHealth:CHFIndependent statistical analysis of Louisiana State University Health Care Sciences Division (LSU HSCD) Tele-Health Projects: Adult CHF Patient Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TeleHepC Treatment Trial: Complete Statistical AnalysisIndependent statistical analysis of TeleHepC Treatment Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04798521).
- Telemedicine Intervention to Improve Physical Function: Complete Statistical AnalysisIndependent statistical analysis of Telemedicine Intervention to Improve Physical Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01639469).
- Telemedicine Interventions for Obstructive Sleep Apnea (OSA): Complete Statistical AnalysisIndependent statistical analysis of Telemedicine Interventions for Obstructive Sleep Apnea (OSA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01108081).
- Telephone-based Care for OEF/OIF Veterans With PTSD: Complete Statistical AnalysisIndependent statistical analysis of Telephone-based Care for OEF/OIF Veterans With PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00680524).
- Telephone-Delivered Cognitive Behavior Therapy for Chronic Pain: Complete Statistical AnalysisIndependent statistical analysis of Telephone-Delivered Cognitive Behavior Therapy for Chronic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00371267).
- Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers: Complete Statistical AnalysisIndependent statistical analysis of Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04058886).
- Telephone-linked Home-based Exercise Training in PD: Complete Statistical AnalysisIndependent statistical analysis of Telephone-linked Home-based Exercise Training in PD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02898740).
- Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury: Complete Statistical AnalysisIndependent statistical analysis of Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00676182).
- Telerehabilitation in the Home Versus Therapy In-Clinic for Patients With Stroke: Complete Statistical AnalysisIndependent statistical analysis of Telerehabilitation in the Home Versus Therapy In-Clinic for Patients With Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome): Complete Statistical AnalysisIndependent statistical analysis of TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00553267).
- telosIndependent statistical analysis of Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPD:…
- Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.: Complete Statistical AnalysisIndependent statistical analysis of Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma: Complete Statistical AnalysisIndependent statistical analysis of Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Temozolomide and Radiation Therapy in Treating Patients With Gliomas: Complete Statistical AnalysisIndependent statistical analysis of Temozolomide and Radiation Therapy in Treating Patients With Gliomas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00114140).
- Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases: Complete Statistical AnalysisIndependent statistical analysis of Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00026494).
- Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme: Complete Statistical AnalysisIndependent statistical analysis of Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Temperature Control in Central Fever in the Neuro-ICU: Complete Statistical AnalysisIndependent statistical analysis of Temperature Control in Central Fever in the Neuro-ICU: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00751634).
- TEMPOIndependent statistical analysis of A Phase 2 Study Comparing 2 Intermittent Dosing Schedules of Duvelisib in Participants With Indolent Non-Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Temporomandibular Disorder (TMD) Pain in Response to Jaw Advancement in People With TMD and Obstructive Sleep Apnea: Complete Statistical AnalysisIndependent statistical analysis of Temporomandibular Disorder (TMD) Pain in Response to Jaw Advancement in People With TMD and Obstructive Sleep Apnea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC): Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus + Weekly Paclitaxel + Carboplatin for Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01020305).
- TEMSOIndependent statistical analysis of Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TendrilMRI™Independent statistical analysis of Safety and Efficacy Study of Tendril MRI™ Leads in Standard Bradycardia Pacing Indication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- TENEREIndependent statistical analysis of A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B: Complete Statistical AnalysisIndependent statistical analysis of Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM): Complete Statistical AnalysisIndependent statistical analysis of Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TENS and Opioid Use After Cesarean Delivery: Complete Statistical AnalysisIndependent statistical analysis of TENS and Opioid Use After Cesarean Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03843788).
- TEOSYAL® RHA Global Action, TEOSYAL® RHA Deep Lines, and Juvéderm® Ultra XC for the Correction of Nasolabial Folds: Complete Statistical AnalysisIndependent statistical analysis of TEOSYAL® RHA Global Action, TEOSYAL® RHA Deep Lines, and Juvéderm® Ultra XC for the Correction of Nasolabial Folds: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Tepotinib Drug-Drug Interaction Study With Carbamazepine in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of Tepotinib Drug-Drug Interaction Study With Carbamazepine in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05213481).
- Tepotinib Hepatic Impairment Trial: Complete Statistical AnalysisIndependent statistical analysis of Tepotinib Hepatic Impairment Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03546608).
- Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT): Complete Statistical AnalysisIndependent statistical analysis of Tepotinib With Gefitinib in Participants With Locally Advanced or Metastatic NSCLC (INSIGHT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00833664).
- Terbinafine HCl 250 mg Tablet Under Fasting Conditions: Complete Statistical AnalysisIndependent statistical analysis of Terbinafine HCl 250 mg Tablet Under Fasting Conditions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00833586).
- TERIKIDSIndependent statistical analysis of Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia: Complete Statistical AnalysisIndependent statistical analysis of Teriparatide (Forteo) in the Treatment of Patients With Postoperative Hypocalcemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00623974).